Uproleselan, Azacitidine, and Venetoclax for the Treatment of Treatment Naive Acute Myeloid Leukemia
Clinical trial NCT04964505 · TERMINATED
Trial details
- NCT number
- NCT04964505
- Sponsor
- Brian Jonas
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-02
- Primary completion
- 2024-10-04
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.